74
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Anti-Inflammatory Activity of Seed Extracts of Aframomum melegueta

, , , &
Pages 11-21 | Received 05 Dec 2004, Published online: 17 Oct 2008
 

ABSTRACT

A methanol extract and fractions (pet ether and methanol) of Aframomum melegueta K. Schum (Zingiberacea) seeds were evaluated for anti-inflammatory activity. An acute toxicity test in mice was used to establish an i.p. LD50 of 2154 mg/kg for the methanol extract. The methanol extract and the pet ether fraction (oil) significantly (P < 0.05) inhibited xylene-induced topical edema in the mouse ear. In contrast, the methanol soluble fraction exhibited no topical anti-inflammatory activity. The methanol extract and the pet ether and methanol fractions had systemic anti-inflammatory activity, significantly (P < 0.05) inhibiting rat paw edema induced by egg albumin. An ulcerogenic assay in rats revealed zero ulcer incidence for the methanol extract and the pet ether and methanol fractions, suggesting a possible non-inhibition of prostaglandin synthesis. Phytochemical analysis of the methanol extract revealed the presence of alkaloids, glycosides, tannins, flavonoids, sterols, triterpenes, and oils, while the methanol fraction contained alkaloids, glycosides, tannins, flavonoids, sterols, and resins. The study results indicate that seeds of Aframomum melegueta possess potent anti-inflammatory activity with a favorable gastric tolerability profile.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.